Molecular biologist Florian Wurm, Ph.D., co-founded ExcellGene in 2001 to improve large-scale mammalian cell manufacturing processes. While working for 10 years at Genentech, Hoechst, and academic ...

Hoping to speed up scaleup through detailed modeling of bioreactors, SimVantage, which was founded in December 2021, is working with pharmaceutical companies to help them scale up their bioreactors ...

Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...

Pluristem Therapeutics Inc. (Haifa, Israel, www.pluristem.com), a leading developer of placenta-based cell therapies, announced that it has initiated the process of scaling up the Company’s ...

Twenty-first century technology is gaining momentum in the staid business of wastewater treatment. Since the federal Water Pollution Control Act of 1972 fueled the buildout of the nation’s current ...